Vanguard Personalized Indexing Management
RCKT icon

Vanguard Personalized Indexing Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.1K Sell
16,116
-9,616
-37% -$32K ﹤0.01% 2130
2026
Q1 		$92.1K Buy
+25,732
New +$102K ﹤0.01% 1960
2025
Q4 		– Sell
-10,418
Closed -$34K – 2048
2025
Q3 		$34K Sell
10,418
-1,933
-16% -$6.09K ﹤0.01% 1939
2025
Q2 		$30.3K Sell
12,351
-7,433
-38% -$37.7K ﹤0.01% 1874
2025
Q1 		$132K Buy
19,784
+2,402
+14% +$23.7K ﹤0.01% 1576
2024
Q4 		$218K Buy
+17,382
New +$262K ﹤0.01% 1488

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Personalized Indexing Management's RCKT Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Rocket Pharmaceuticals (RCKT) stake by 37% in Q2 2026, selling an estimated $32K and leaving 16,116 shares worth $55.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2130.

Vanguard Personalized Indexing Management first reported a position in RCKT in Q4 2024 and has held it in 6 quarters since. The position peaked at $218K in Q4 2024. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Vanguard Personalized Indexing Management held 16,116 shares of Rocket Pharmaceuticals worth $55.1K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 9,616 Rocket Pharmaceuticals shares in Q2 2026, an estimated $32K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2130 holding.
  • Vanguard Personalized Indexing Management first reported a position in Rocket Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Vanguard Personalized Indexing Management's Rocket Pharmaceuticals position peaked at $218K in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.